Inhibitory effect on an anti-oxidant, butylated hydroxyanisole, on the primary in vitro immune response.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology*; D000917:Antibody Formation / Q000187:drug effects*; D002083:Butylated Hydroxyanisole / Q000494:pharmacology*; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004912:Erythrocytes / Q000276:immunology; D004926:Escherichia coli; D005260:Female; D007165:Immunosuppression Therapy; D008070:Lipopolysaccharides / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012756:Sheep; D013154:Spleen / Q000276:immunology; D013997:Time Factors
D000840:Anisoles; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D003208:Concanavalin A; D002083:Butylated Hydroxyanisole; D004247:DNA